FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904804846> ?p ?o ?g. }

• W2904804846 abstract "The ever-increasing cost of healthcare together with our improved understanding of biotech therapeutic drugs has fueled the rise of biosimilars. A step towards achieving the successful development of a biosimilar is to establish analytical similarity with the innovator drug. This is necessary so as to avail the significant reduction in clinical data required for achieving regulatory approval. A key concern is the limited understanding of how the different quality attributes (QA) affect its safety and efficacy profile. India has successfully demonstrated its ability to make affordable, high-quality pharmaceutical products for the world, particularly the small molecule generics. This fact is validated by the trend that the share of Indian made pharmaceutical products in the US market has been constantly increasing and is presently more than 30%. The question is if India can successfully replicate its success, in manufacturing complex biotherapeutic products. This chapter explores India’s journey in the field of biosimilar manufacturing with an emphasis on the regulatory aspect. Followed by a concise overview of the evolution of global regulatory guidelines, the Indian framework has been discussed in detail. Major changes introduced in the latest guidelines for similar biologics (2016) have been highlighted. Insight into the key developments related to clinical experiences and thereby addition of more sophisticated platforms to the analytical armory in the past decade for characterization of biosimilars has been given. Two recently published case studies on analytical platform approach used to establish similarity for microbial (GCSF) and mammalian product (Rituximab), in the Indian marketplace, using an array of advanced, orthogonal, high-resolution analytical methods, have been discussed. Finally, the importance post-approval pharmacovigilance as a feedback mechanism to update and improve existing regulatory framework has been outlined." @default.
• W2904804846 created "2018-12-22" @default.
• W2904804846 creator A5017226658 @default.
• W2904804846 creator A5034990841 @default.
• W2904804846 creator A5057209120 @default.
• W2904804846 creator A5078008569 @default.
• W2904804846 date "2018-01-01" @default.
• W2904804846 modified "2023-09-28" @default.
• W2904804846 title "Development and Commercialization of Biosimilars in India: Current Regulatory and Clinical Experience" @default.
• W2904804846 cites W1629918075 @default.
• W2904804846 cites W1996046224 @default.
• W2904804846 cites W1996898871 @default.
• W2904804846 cites W1997290803 @default.
• W2904804846 cites W1997780934 @default.
• W2904804846 cites W2006893257 @default.
• W2904804846 cites W2013209780 @default.
• W2904804846 cites W2014182348 @default.
• W2904804846 cites W2037604822 @default.
• W2904804846 cites W2038947914 @default.
• W2904804846 cites W2047546034 @default.
• W2904804846 cites W2056762024 @default.
• W2904804846 cites W2058978779 @default.
• W2904804846 cites W2075487419 @default.
• W2904804846 cites W2099292375 @default.
• W2904804846 cites W2133113022 @default.
• W2904804846 cites W2163758618 @default.
• W2904804846 cites W2176501839 @default.
• W2904804846 cites W2402101907 @default.
• W2904804846 cites W2605691647 @default.
• W2904804846 cites W2771153738 @default.
• W2904804846 cites W4240857640 @default.
• W2904804846 cites W4251331705 @default.
• W2904804846 cites W4254964954 @default.
• W2904804846 cites W4255836985 @default.
• W2904804846 doi "https://doi.org/10.1007/978-3-319-99680-6_24" @default.
• W2904804846 hasPublicationYear "2018" @default.
• W2904804846 type Work @default.
• W2904804846 sameAs 2904804846 @default.
• W2904804846 citedByCount "0" @default.
• W2904804846 crossrefType "book-chapter" @default.
• W2904804846 hasAuthorship W2904804846A5017226658 @default.
• W2904804846 hasAuthorship W2904804846A5034990841 @default.
• W2904804846 hasAuthorship W2904804846A5057209120 @default.
• W2904804846 hasAuthorship W2904804846A5078008569 @default.
• W2904804846 hasConcept C111472728 @default.
• W2904804846 hasConcept C111919701 @default.
• W2904804846 hasConcept C112930515 @default.
• W2904804846 hasConcept C138885662 @default.
• W2904804846 hasConcept C142724271 @default.
• W2904804846 hasConcept C144133560 @default.
• W2904804846 hasConcept C150903083 @default.
• W2904804846 hasConcept C162853370 @default.
• W2904804846 hasConcept C19351080 @default.
• W2904804846 hasConcept C204320433 @default.
• W2904804846 hasConcept C2524010 @default.
• W2904804846 hasConcept C2776473838 @default.
• W2904804846 hasConcept C2778917124 @default.
• W2904804846 hasConcept C2779134260 @default.
• W2904804846 hasConcept C2779530757 @default.
• W2904804846 hasConcept C2779652045 @default.
• W2904804846 hasConcept C2780035454 @default.
• W2904804846 hasConcept C2780625559 @default.
• W2904804846 hasConcept C2908701176 @default.
• W2904804846 hasConcept C33923547 @default.
• W2904804846 hasConcept C34974158 @default.
• W2904804846 hasConcept C41008148 @default.
• W2904804846 hasConcept C59491497 @default.
• W2904804846 hasConcept C64903051 @default.
• W2904804846 hasConcept C71924100 @default.
• W2904804846 hasConcept C86803240 @default.
• W2904804846 hasConcept C90673727 @default.
• W2904804846 hasConcept C98274493 @default.
• W2904804846 hasConceptScore W2904804846C111472728 @default.
• W2904804846 hasConceptScore W2904804846C111919701 @default.
• W2904804846 hasConceptScore W2904804846C112930515 @default.
• W2904804846 hasConceptScore W2904804846C138885662 @default.
• W2904804846 hasConceptScore W2904804846C142724271 @default.
• W2904804846 hasConceptScore W2904804846C144133560 @default.
• W2904804846 hasConceptScore W2904804846C150903083 @default.
• W2904804846 hasConceptScore W2904804846C162853370 @default.
• W2904804846 hasConceptScore W2904804846C19351080 @default.
• W2904804846 hasConceptScore W2904804846C204320433 @default.
• W2904804846 hasConceptScore W2904804846C2524010 @default.
• W2904804846 hasConceptScore W2904804846C2776473838 @default.
• W2904804846 hasConceptScore W2904804846C2778917124 @default.
• W2904804846 hasConceptScore W2904804846C2779134260 @default.
• W2904804846 hasConceptScore W2904804846C2779530757 @default.
• W2904804846 hasConceptScore W2904804846C2779652045 @default.
• W2904804846 hasConceptScore W2904804846C2780035454 @default.
• W2904804846 hasConceptScore W2904804846C2780625559 @default.
• W2904804846 hasConceptScore W2904804846C2908701176 @default.
• W2904804846 hasConceptScore W2904804846C33923547 @default.
• W2904804846 hasConceptScore W2904804846C34974158 @default.
• W2904804846 hasConceptScore W2904804846C41008148 @default.
• W2904804846 hasConceptScore W2904804846C59491497 @default.
• W2904804846 hasConceptScore W2904804846C64903051 @default.
• W2904804846 hasConceptScore W2904804846C71924100 @default.
• W2904804846 hasConceptScore W2904804846C86803240 @default.
• W2904804846 hasConceptScore W2904804846C90673727 @default.
• W2904804846 hasConceptScore W2904804846C98274493 @default.

• next